Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant manifestation of cutaneous and uterine leiomyomas together with renal cancer due to autosomal dominant germline mutations of fumarate hydratase gene. A twenty-year-old female patient presented with type-II segmental piloleiomyoma and increased menstruation due to uterine leiomyomas, with a history of bilateral nephrectomy performed at 13 and 16 years of age for type 2 papillary renal cell carcinoma. This case represents one of the very early onsets of hereditary leiomyomatosis and renal cell carcinoma syndrome. As genetic anticipation for renal cancer is a well-documented entity for HLRCC syndrome, early recognition is crucial for both the patient and her family in order to provide appropriate counseling and initiation of surveillance.
INTRODUCTION
The leiomyomas of the skin were first described by Virchow in 1854 as rare, slow growing, benign, smooth muscle tumors on the skin. The association between the leiomyomas and the inherited susceptibility to renal cancer could be first recognized in 2001. Up to date there have been only 180 families identified with hereditary leiomyomatosis and renal cell carcinoma (HLRCC). 1 The common mechanism beneath the HLRCC syndrome is the heterozygous germline mutations encountered in fumarate hydratase (FH) gene located at 1q42.3-43. 2 We present the case of a 20-year-old patient with HLRCC, who initially presented with renal cancer at 13 years of age without a supportive family history. As the literature shows genetic anticipation, all of the recommended protective measures are mainly centered on the assessment of the siblings in the affected families. In contrast,
here we questioned the presence of HLRCC in the older generations. cancer is the major life-threatening feature of the syndrome. 6 As the most common type-2 papillary renal cell carcinoma is often isoechoic on ultrasound, MRI would be more appropriate for screening.
CASE REPORT
Also, genetic counseling is very important in patients with a family history of HRLCC, because there is potential for diagnosis in an asymptomatic state. Genetic evaluation could not be performed due to technical difficulty. We believe that our patient was potentially the second generation of HRLCC in her family, as her mother and aunt were still in the third decade. To us, these family 
